Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Genetic Association Analyses Highlight IL6 , ALPL , and NAV1 As 3 New Susceptibility Genes Underlying Calcific Aortic Valve Stenosis
Ist Teil von
Circulation. Genomic and precision medicine, 2019-10, Vol.12 (10), p.e002617-e002617
Ort / Verlag
United States: American Heart Association
Erscheinungsjahr
2019
Quelle
MEDLINE
Beschreibungen/Notizen
Calcific aortic valve stenosis (CAVS) is a frequent and life-threatening cardiovascular disease for which there is currently no medical treatment available. To date, only 2 genes,
and
, have been identified as causal for CAVS. We aimed to identify additional susceptibility genes for CAVS.
A GWAS (genome-wide association study) meta-analysis of 4 cohorts, totaling 5115 cases and 354 072 controls of European descent, was performed. A TWAS (transcriptome-wide association study) was completed to integrate transcriptomic data from 233 human aortic valves. A series of post-GWAS analyses were performed, including fine-mapping, colocalization, phenome-wide association studies, pathway, and tissue enrichment as well as genetic correlation with cardiovascular traits.
In the GWAS meta-analysis, 4 loci achieved genome-wide significance, including 2 new loci:
(interleukin 6) on 7p15.3 and
(alkaline phosphatase) on 1p36.12. A TWAS integrating gene expression from 233 human aortic valves identified
(neuron navigator 1) on 1q32.1 as a new candidate causal gene. The CAVS risk alleles were associated with higher mRNA expression of
in valve tissues. Fine-mapping identified rs1800795 as the most likely causal variant in the
locus. The signal identified colocalizes with the expression of the
RNA antisense in various tissues. Phenome-wide association analyses in the UK Biobank showed colocalized associations between the risk allele at the
lead variant and higher eosinophil count, pulse pressure, systolic blood pressure, and carotid artery procedures, implicating modulation of the IL6 pathways. The risk allele at the
lead variant colocalized with higher pulse pressure and higher prevalence of carotid artery stenosis. Association results at the genome-wide scale indicated genetic correlation between CAVS, coronary artery disease, and cardiovascular risk factors.
Our study implicates 3 new genetic loci in CAVS pathogenesis, which constitute novel targets for the development of therapeutic agents.